摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-bromo-2,5-bis(3-methoxyphenyl)thiophene | 1193525-53-9

中文名称
——
中文别名
——
英文名称
3-bromo-2,5-bis(3-methoxyphenyl)thiophene
英文别名
——
3-bromo-2,5-bis(3-methoxyphenyl)thiophene化学式
CAS
1193525-53-9
化学式
C18H15BrO2S
mdl
——
分子量
375.286
InChiKey
MCOKNRACGHWKDW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    46.7
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-bromo-2,5-bis(3-methoxyphenyl)thiophene3-甲氧基苯硼酸四(三苯基膦)钯sodium carbonate 作用下, 以 甲苯 为溶剂, 反应 20.0h, 以34%的产率得到2,3,5-tris(3-methoxyphenyl)thiophene
    参考文献:
    名称:
    New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
    摘要:
    17 beta-Hydroxystcroid dehydrogenase type 1 (17 beta-HSD1) is responsible for the catalytic reduction of weakly active E1 to highly potent E2. E2 stimulates the proliferation of hormone-dependent diseases via activation of the estrogen receptor alpha (ER alpha). Because of the overexpression of 17 beta-HSD1 in mammary tumors, this enzyme should be an attractive target for the treatment of estrogen-dependent pathologies. Recently, we have reported on a series of potent 17 beta-HSD1 inhibitors: bis(hydroxyphenyl) azoles, thiophenes, and benzenes. In this paper, different substituents are introduced into the core structure and the biological properties of the corresponding inhibitors are evaluated. Computational methods and analysis of different X-rays of 17 beta-HSD1 lead to identification of two different binding modes for these inhibitors. The fluorine compound 23 exhibits an IC50 of 8 nM and is the most potent nonsteroidal inhibitor described so far. It also shows a high selectivity (17 beta-HSD2, ER alpha) and excellent pharmacokinetic properties after peroral application to rats.
    DOI:
    10.1021/jm901195w
  • 作为产物:
    描述:
    3,5-dibromo-2-(3-methoxyphenyl)thiophene3-甲氧基苯硼酸四(三苯基膦)钯sodium carbonate 作用下, 以 甲苯 为溶剂, 反应 20.0h, 以72%的产率得到3-bromo-2,5-bis(3-methoxyphenyl)thiophene
    参考文献:
    名称:
    New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity
    摘要:
    17 beta-Hydroxystcroid dehydrogenase type 1 (17 beta-HSD1) is responsible for the catalytic reduction of weakly active E1 to highly potent E2. E2 stimulates the proliferation of hormone-dependent diseases via activation of the estrogen receptor alpha (ER alpha). Because of the overexpression of 17 beta-HSD1 in mammary tumors, this enzyme should be an attractive target for the treatment of estrogen-dependent pathologies. Recently, we have reported on a series of potent 17 beta-HSD1 inhibitors: bis(hydroxyphenyl) azoles, thiophenes, and benzenes. In this paper, different substituents are introduced into the core structure and the biological properties of the corresponding inhibitors are evaluated. Computational methods and analysis of different X-rays of 17 beta-HSD1 lead to identification of two different binding modes for these inhibitors. The fluorine compound 23 exhibits an IC50 of 8 nM and is the most potent nonsteroidal inhibitor described so far. It also shows a high selectivity (17 beta-HSD2, ER alpha) and excellent pharmacokinetic properties after peroral application to rats.
    DOI:
    10.1021/jm901195w
点击查看最新优质反应信息

文献信息

  • DIARYLETHENE COMPOUNDS AND USES THEREOF
    申请人:SWITCH MATERIALS, INC.
    公开号:US20160083398A1
    公开(公告)日:2016-03-24
    A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R 1 is independently selected from the group consisting of H, or halo; each R 2 is independently selected from the group consisting of H, halo, a polymer backbone, alkyl or aryl; or, when both R 2 together form —CH═CH— and form part of a polymer backbone; each R 3 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl; each R 4 is aryl; and each R 5 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl.
    本发明提供了一种按照式IA和IB的化合物,在光致变色和电致变色条件下,可在环开放异构体A和环闭合异构体B之间可逆地转化。对于取代基,Z为N、O或S;每个R1独立地选自H或卤素;每个R2独立地选自H、卤素、聚合物骨架、烷基或芳基;或者,当两个R2一起形成-CH═CH-并形成聚合物骨架的一部分时;每个R3独立地选自H、卤素、烷基、烷氧基、代烷基或芳基;每个R4为芳基;每个R5独立地选自H、卤素、烷基、烷氧基、代烷基或芳基。
  • Diarylethene compounds and uses thereof
    申请人:SWITCH MATERIALS, INC.
    公开号:US10072023B2
    公开(公告)日:2018-09-11
    A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R1 is independently selected from the group consisting of H, or halo; each R2 is independently selected from the group consisting of H, halo, a polymer backbone, alkyl or aryl; or, when both R2 together form —CH═CH— and form part of a polymer backbone; each R3 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl; each R4 is aryl; and each R5 is independently selected from the group consisting of H, halo, alkyl, alkoxy, thioalkyl or aryl.
    提供了一种根据式 IA 和 IB 的化合物,该化合物在光致变色和电致变色条件下可在开环异构体 A 和闭环异构体 B 之间进行可逆转换。对于取代基,Z 是 N、O 或 S;每个 R1 独立地选自 H 或卤代;每个 R2 独立地选自 H、卤代、聚合物骨架、烷基或芳基;或者,当两个 R2 一起形成 -CH═CH- 并构成聚合物骨架的一部分时;每个 R3 独立地选自由 H、卤素、烷基、烷氧基、代烷基或芳基组成的组;每个 R4 是芳基;每个 R5 独立地选自由 H、卤素、烷基、烷氧基、代烷基或芳基组成的组。
  • PHOTOCHROMIC AND ELECTROCHROMIC DIARYLCYCLOPENTENE DERIVATIVES AS OPTICAL FILTERS
    申请人:Switch Materials, Inc.
    公开号:EP2760969A1
    公开(公告)日:2014-08-06
  • US20140256936A1
    申请人:——
    公开号:US20140256936A1
    公开(公告)日:2014-09-11
  • US9227986B2
    申请人:——
    公开号:US9227986B2
    公开(公告)日:2016-01-05
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯